Caxton Associates (New York)’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,532
| Closed | -$930K | – | 646 |
|
|
2023
Q1 | $930K | Buy |
+12,532
| New | +$930K | 0.14% | 154 |
|
|
2022
Q4 | – | Sell |
-3,012
| Closed | -$214K | – | 583 |
|
|
2022
Q3 | $214K | Buy |
+3,012
| New | +$214K | 0.03% | 373 |
|
|
2022
Q1 | – | Sell |
-4,312
| Closed | -$558K | – | 664 |
|
|
2021
Q4 | $558K | Buy |
+4,312
| New | +$558K | 0.06% | 233 |
|
|
2019
Q3 | – | Sell |
-8,692
| Closed | -$453K | – | 535 |
|
|
2019
Q2 | $453K | Hold |
8,692
| – | – | 0.05% | 196 |
|
|
2019
Q1 | $431K | Buy |
+8,692
| New | +$431K | 0.06% | 165 |
|